Skip to content

PROCEPT BioRobotics Corporation PRCT Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Boston Scientific logo
Boston ScientificBSX
Intuitive Surgical logo
Intuitive SurgicalISRG
UFP Technologies logo
UFP TechnologiesUFPT
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
iRadimed logo
iRadimedIRMD
Oceaneering International logo
Oceaneering InternationalOII

Other financials

Income statement

See full
Revenue$83.1M+20.2%
Gross profit$53.9M+22.2%
Operating income-$32.6M-18.8%
Net income-$31.6M-27.9%
EPS (diluted)-$0.56-24.4%

Balance sheet

See full
Cash & equivalents$12.2M-96.2%
Total debt$78.0M-11.8%
Total equity$347.7M-10.7%
Total assets$487.1M-6.2%

Cash flow

See full
Operating cash flow-$38.1M-125%
CapEx$2.9M+58.7%
Free cash flow-$41.0M-118%

Valuation

See full
Market cap$1.19B-24.8%
Enterprise value$1.25B
P/S3.7×

Profitability

See full
Gross margin64%+1.3pp
Operating margin-33.9%-3.8pp
Net margin-31.8%-3.4pp
FCF margin-25%-5.7pp

Returns & leverage

See full
Return on equity-27.8%+0.2pp
Debt / equity0.2×0.0×
Current ratio6.7×-2.2×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: PROCEPT BioRobotics Corporation’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about PROCEPT BioRobotics Corporation's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PROCEPT BioRobotics Corporation's common stock, shares authorized (in shares)?
PROCEPT BioRobotics Corporation (PRCT) reported common stock, shares authorized (in shares) of $300M in Q1 2026.
How has PROCEPT BioRobotics Corporation's common stock, shares authorized (in shares) changed year-over-year?
PROCEPT BioRobotics Corporation's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $300M to $300M.
What is the long-term trend for PROCEPT BioRobotics Corporation's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), PROCEPT BioRobotics Corporation's common stock, shares authorized (in shares) has grown at a 49.6% compound annual growth rate (CAGR), from $40M to $300M.